Correlation Between Merck and Pmv Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Merck and Pmv Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Pmv Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and Pmv Pharmaceuticals, you can compare the effects of market volatilities on Merck and Pmv Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Pmv Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Pmv Pharmaceuticals.

Diversification Opportunities for Merck and Pmv Pharmaceuticals

-0.65
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Merck and Pmv is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Pmv Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pmv Pharmaceuticals and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Pmv Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pmv Pharmaceuticals has no effect on the direction of Merck i.e., Merck and Pmv Pharmaceuticals go up and down completely randomly.

Pair Corralation between Merck and Pmv Pharmaceuticals

Considering the 90-day investment horizon Merck Company is expected to under-perform the Pmv Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Merck Company is 2.31 times less risky than Pmv Pharmaceuticals. The stock trades about -0.22 of its potential returns per unit of risk. The Pmv Pharmaceuticals is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  150.00  in Pmv Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of  9.00  from holding Pmv Pharmaceuticals or generate 6.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Merck Company  vs.  Pmv Pharmaceuticals

 Performance 
       Timeline  
Merck Company 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Pmv Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days Pmv Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Pmv Pharmaceuticals is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.

Merck and Pmv Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Merck and Pmv Pharmaceuticals

The main advantage of trading using opposite Merck and Pmv Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Pmv Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pmv Pharmaceuticals will offset losses from the drop in Pmv Pharmaceuticals' long position.
The idea behind Merck Company and Pmv Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.